ASP7374

· UMN Pharma Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ASP7374, covering 2017-09-29 to 2017-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase-3 Study of ASP7374, Cell-culture-derived Influenza Vaccine [Phase 3]